| USD millions | FY2024 | FY2025 |
|---|---|---|
| Revenue | 21.7 | 17.8 |
| Cost of revenue | 20.2 | 14.7 |
| Gross profit | 1.4 | 3.2 |
| Research & development | 0.2 | 0.0 |
| Operating expenses | 13.7 | 11.3 |
| Operating income | (12.2) | (8.1) |
| Interest expense | 1.8 | 2.9 |
| Interest income | 0.1 | 0.1 |
| Pre-tax income | (15.3) | (17.2) |
| Income tax | 0.0 | 0.0 |
| Net income | (15.2) | (14.6) |
| EPS, basic (per share) | (5.62) | (4.56) |
| EPS, diluted (per share) | (5.62) | (4.56) |
| EBITDA | (11.6) | (7.5) |
| Depreciation & amortization | 0.7 | 0.6 |
| Weighted average shares (shares) | 2,710,769 | 3,194,835 |
| Weighted average diluted shares (shares) | 2,710,769 | 3,194,835 |
| Gross margin | 6.6% | 17.9% |
| Operating margin | −56.5% | −45.3% |
| Net margin | −70.3% | −81.7% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.